47
BioStem Technologies, Inc. raises $40M under Reg D
Company raise · Pre-first close · Offering $40M · POMPANO BEACH, FL · filed 2026-09-21
BioStem Technologies, a Florida-incorporated biotechnology company, closed a $3M offering under Regulation D exemption 6(b) on September 29, 2026. The raise drew two investors and is now fully subscribed.
| Jason Matuszewski | Executive Officer, Director |
| Brandon Poe | Executive Officer |
| Andrew Van Vurst | Executive Officer, Director |
| Barry Hassett | Executive Officer |
| Katherine Gorrell | Executive Officer |
| Kenneth Warrington | Director |
| Mark Glickman | Director |
| Rayna Lesser Hannaway | Director |
| Jodi Ungrodt | Director |
| Steven Sonenreich | Director |
Signed by Jason Matuszewski, Chief Executive Officer.
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.